Login / Signup

Complete Primary Pathological Response Following Neoadjuvant Treatment and Radical Resection for Pancreatic Ductal Adenocarcinoma.

Kai Tai Derek YeungJoseph DoyleSacheen KumarKatharine AitkenDiana TaitDavid CunninghamLong R JiaoRicky Harminder Bhogal
Published in: Cancers (2024)
Complete primary pathological response is uncommon but possible following neoadjuvant treatment in patients with PDAC. Further work to identify the common denominator within this unique cohort may lead to advances in the therapeutic approach and offer hope for patients diagnosed with borderline or locally advanced pancreatic ductal adenocarcinoma.
Keyphrases
  • locally advanced
  • rectal cancer
  • squamous cell carcinoma
  • lymph node
  • neoadjuvant chemotherapy
  • end stage renal disease
  • ejection fraction
  • prognostic factors
  • phase ii study
  • open label
  • patient reported